Medicare regulations may be causing shortage of cancer drugs

A month’s long shortage of cancer drugs may be the result of Medicare regulations. For several years, Medicare has provided coverage for cancer patients, allowing them to obtain treatments that they would otherwise have no access to. While Medicare offers this coverage, however, the number of cancer fighting drugs has been falling steadily. The phenomenon may be the result of a regulation within the Medicare system that dictates that doctors must purchase cancer drugs, not patients. Traditionally, patients have been responsible for purchasing their own medications as prescribed to them…

Read More